Kellsye P. Fabian - Concepedia

Author

Kellsye P. Fabian

Also Known As

Fábián K, K Fabian, K Fábián, K. Fabian, Kathryn Fabian, Kellsye Fabian, Kellsye L. Fabian, Kellsye P Fabian, Kellsye P. Fabian, Kellsye P. L. Fabian

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute University of Pittsburgh Center for Cancer Research UPMC Hillman Cancer Center National Institutes of Health

About

Kellsye P. Fabian is an author at National Cancer Institute specializing in immunotherapy, tumor microenvironment, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	119
2	Immunology	4	4	119
3	Cell Biology	3	3	100
4	Pathology	2	2	38
5	Cellular Therapies	1	1	57

Kellsye P. Fabian

Publications

827

Citations

H-Index

Page 1

	Year	Citations
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations Kellsye P. Fabian, Michelle R. Padget, Renee N. Donahue, Journal for ImmunoTherapy of Cancer	2020	143
Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients C. Cordonnier, Rodrigo Martino, Plı́nio Trabasso, Clinical Infectious Diseases	2004	100
Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma Beatrice M. Razzo, Nils Ludwig, Chang‐Sook Hong, Carcinogenesis	2019	83
Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment Aliyah M. Weinstein, Lu Chen, Emily A. Brzana, OncoImmunology	2017	76
Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma Jae‐Yeon Choi, Wissam Beaino, Ronald J. Fecek, Journal of Nuclear Medicine	2018	75
Overcoming hypoxia-induced functional suppression of NK cells Kristen Solocinski, Michelle R. Padget, Kellsye P. Fabian, Journal for ImmunoTherapy of Cancer	2020	65
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells Yvette Robbins, Sarah Greene, Jay Friedman, eLife Cell TherapyTumor ControlImmunologyImmunoeditingNk Cells	2020	57
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve Kellsye P. Fabian, Michelle R. Padget, Rika Fujii, Journal for ImmunoTherapy of Cancer	2021	50
DLK1: A Novel Target for Immunotherapeutic Remodeling of the Tumor Blood Vasculature Nina Chi-Sabins, Jennifer Taylor, Kellsye P. Fabian, Molecular Therapy	2013	39
Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells Austin T.K. Hoke, Michelle R. Padget, Kellsye P. Fabian, Cancer Research Communications	2021	26

Page 1